The WHO has “just called JN.1 a VOI (variant of interest), and that just doesn’t cut it, with the growth advantage this variant has demonstrated. It is just extraordinary”, Dr Eric Topol, founder and director of the Scripps Research Translational Institute in California,US, was quoted as saying to Fortune., The WHO has “just called JN.1 a VOI (variant of interest), and that just doesn’t cut it, with the growth advantage this variant has demonstrated. It is just extraordinary”, Dr Eric Topol, founder and director of the Scripps Research Translational Institute in California,US, was quoted as saying to Fortune., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way